Recent Company News

• 11:08 AM ET Oct 17, 2025
  

  Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target

• 06:28 PM ET Oct 12, 2025
  

  Immuron reports Q1 Global Travelan sales A$2.0M, +34% vs pcp (A$0.09, 0.00)

• 09:53 PM ET Oct 01, 2025
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 05:55 PM ET Oct 07, 2025
  

  Immuron submits IND application for IMM-529 to FDA (A$0.09, 0.00)

• 09:35 PM ET Oct 05, 2025
  

  Immuron extends ATM funding facility with HC Wainwright (A$0.09, 0.00)

• 06:32 PM ET Oct 01, 2025
  

  Immuron does not anticipate any material impact from the recently announced US tariffs on pharmaceutical products (A$0.08, 0.00)

• 09:49 PM ET Sep 22, 2025
  

  StreetAccount Summary - Australia unusual volume traders

• 07:30 PM ET Sep 15, 2025
  

  Immuron issues product portfolio update in investor presentation (A$0.07, 0.00)